Coronavirus latest news: The devastation of the second wave of Corona virus continues within the country. Meanwhile, warnings are issued about the third wave of the epidemic, which is predicted to infect the most children. in sight of this, an enormous step has been taken. An expert committee on Tuesday recommended testing for the second / third phase of Bharat Biotech’s Covid vaccine for ages 2 to 18, which has been approved by the govt of India. Official sources gave this information.
The Subject Expert Committee (SEC) on the Corona Vaccine recommended on Tuesday that India should approve the second and third phase clinical trials of Biotech covaccine, which can be done on children between 2 and 18 years of age. The test will be conducted at various places including AIIMS in Delhi and Patna and therefore the Meditrina Institute of Medical Sciences in Nagpur.
The company had asked for permission
Let us know that the covid-19 Subject Expert Committee of the Central Drugs Standard Control Organization (CDSCO) on Tuesday discussed the appliance made by Bharat Biotech, during which the security and disease of its covaxine vaccine in children between two and 18 years aged it had been requested to allow the second / third phase of the test to assess other things including increasing the immunity. A source said that after detailed deliberations on the company’s application, the committee had recommended allowing the proposed second/third stage test.
Explain that the two covid vaccines are getting used in India thus far . Both of them are under clinical test on people above 18 years aged . covishield of Serum Institute in India, Bharat Biotech’s covaxin are being offered to the public. In such a situation, it’s considered an enormous decision to approve the trial on children before warning of the third wave.